NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation

ConclusionsThe results of this study suggest that NOAC therapy without additional antiplatelet treatment is effective and safe in patients with concomitant indications for OAC undergoing TAVI.

http://link.springer.com/10.1007/s00392-018-1247-x

Source: Clinical Research in Cardiology - April 11, 2018 Category: Cardiology Source Type: research